Chemical
proteomics is widely used for the global investigation
of protein activity and binding of small molecule ligands. Covalent
probe binding and inhibition are assessed using liquid chromatography-tandem
mass spectrometry (LC-MS/MS) to gain molecular information on targeted
proteins and probe-modified sites. The identification of amino acid
sites modified by large complex probes, however, is particularly challenging
because of the increased size, hydrophobicity, and charge state of
peptides derived from modified proteins. These studies are important
for direct evaluation of proteome-wide selectivity of inhibitor scaffolds
used to develop targeted covalent inhibitors. Here, we disclose reverse-phase
chromatography and MS dissociation conditions tailored for binding
site identification using a clickable covalent kinase inhibitor containing
a sulfonyl–triazole reactive group (KY-26). We applied this
LC-MS/MS strategy to identify tyrosine and lysine sites modified by
KY-26 in functional sites of kinases and other ATP-/NAD-binding proteins
(>65 in total) in live cells. Our studies revealed key bioanalytical
conditions to guide future chemical proteomic workflows for direct
target site identification of complex irreversible probes and inhibitors